Aclaris Therapeutics (ACRS) Asset Utilization Ratio (2017 - 2025)
Aclaris Therapeutics (ACRS) has 9 years of Asset Utilization Ratio data on record, last reported at 0.05 in Q4 2025.
- For Q4 2025, Asset Utilization Ratio fell 49.89% year-over-year to 0.05; the TTM value through Dec 2025 reached 0.05, down 49.89%, while the annual FY2025 figure was 0.04, 54.14% down from the prior year.
- Asset Utilization Ratio reached 0.05 in Q4 2025 per ACRS's latest filing, down from 0.09 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.19 in Q2 2024 and bottomed at 0.02 in Q2 2022.
- Average Asset Utilization Ratio over 5 years is 0.09, with a median of 0.09 recorded in 2025.
- Peak YoY movement for Asset Utilization Ratio: plummeted 71.08% in 2021, then soared 450.24% in 2023.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.03 in 2021, then soared by 333.71% to 0.11 in 2022, then surged by 31.93% to 0.15 in 2023, then plummeted by 38.15% to 0.09 in 2024, then plummeted by 49.89% to 0.05 in 2025.
- Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.05 in Q4 2025, 0.09 in Q3 2025, and 0.09 in Q2 2025.